Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GLYR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CDC42SE2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RCC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HNRNPH3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP1R7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARPC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
COPE - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPFIA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEP83-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
EIF5B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EHD4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRELID1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MTG2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DDX11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC39A14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TCF25 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NFKBIB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on